EPIC | SBTX |
Sector | Pharma and Biotech |
ISIN | GB00BF33H870 |
Market Sector | AIM |
Market Segment | ASQ1 |
Main Indices | FTSE AIM All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £42.70m |
NMS | 7,500 |
Shares in issue | 258.78m |
Date Listed | n/a |
Currency | UK Pounds |
Share Price | 16.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 26.10 |
52 Week Low | 8.50 |
Volume | 0 |
Shares Issued | 258.78m |
Market Cap | £42.70m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research